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LC8 dynein light chain (DYNLL) is a highly conserved eu-
karyotic hub protein with dozens of binding partners and vari-
ous functions beyond being a subunit of dynein and myosin Va
motor proteins. Here, we compared the kinetic and thermody-
namic parameters of binding of both mammalian isoforms,
DYNLL1 and DYNLL2, to two putative consensus binding mo-
tifs (KXTQTX and XG(I/V)QVD) and report only subtle differ-
ences. Peptides containing either of the above motifs bind to
DYNLL2 with micromolar affinity, whereas a myosin Va pep-
tide (lacking the conserved Gln) and the noncanonical Pak1
peptide bind with Kd values of 9 and 40 M, respectively. Bind-
ing of the KXTQTXmotif is enthalpy-driven, although that of
all other peptides is both enthalpy- and entropy-driven. More-
over, the KXTQTXmotif shows strikingly slower off-rate con-
stant than the other motifs. As most DYNLL partners are ho-
modimeric, we also assessed the binding of bivalent ligands to
DYNLL2. Compared with monovalent ligands, a significant
avidity effect was found as follows: Kd values of 37 and 3.5 nM
for a dimeric myosin Va fragment and a Leu zipper dimerized
KXTQTXmotif, respectively. Ligand binding kinetics of
DYNLL can best be described by a conformational selection
model consisting of a slow isomerization and a rapid binding
step. We also studied the binding of the phosphomimetic S88E
mutant of DYNLL2 to the dimeric myosin Va fragment, and we
found a significantly lower apparent Kd value (3 M). We con-
clude that the thermodynamic and kinetic fine-tuning of bind-
ing of various ligands to DYNLL could have physiological rele-
vance in its interaction network.
LC8 dynein light chain (DYNLL)3 is a highly conserved
small eukaryotic protein. It was originally discovered as a light
chain of the dynein (1) and later of myosin Va (myoVa) (2)
motor protein complexes. However, DYNLL has many inter-
action partners unrelated to motor proteins. Therefore, it has
been suggested that DYNLL is a hub protein that plays impor-
tant roles in the interactome of eukaryotic cells in various
cellular events, including apoptosis, molecular, organelle, and
nuclear transport, viral infection, cancer development, and
transcription regulation (3, 4). More intensively studied
DYNLL-binding proteins include neuronal nitric-oxide syn-
thase (nNOS) (5), myoVa (2), Bcl-2-modifying factor (Bmf)
(6), Bcl-2 interacting mediator (Bim) (7), dynein intermediate
chain (DIC) (8), the Drosophila swallow mRNA localizing
protein (9), and p21-activated protein kinase 1 (Pak1) (10, 11).
Several solution and crystal structures of apo-DYNLL and
complexes with binding peptides have been determined (12–
20). DYNLL has a homodimeric structure, and the bound
partner peptides lie in two identical grooves formed at the
dimerization interface (12–20). Formerly, it was widely as-
sumed that DYNLL could function as a cargo adapter on dy-
nein and myoVa motors (6, 21, 22). However, this hypothesis
is difficult to reconcile with the symmetric homodimeric
structure of DYNLL and most of its partners, including
myoVa and DIC. Instead, it has been suggested, based on the
effect of DYNLL on its partner proteins, that one of the major
roles of DYNLL dimers could be the ability to promote dimer-
ization and stabilization of their interaction partners (2, 3, 23).
DYNLL has two mammalian isoforms (DYNLL1 and
DYNLL2; previously known as DLC1 and DLC2 or LC8a and
LC8b) (21, 22) that differ from each other only in six residues.
All of these residues are located outside of the ligand binding
grooves. Despite their similarity, DYNLL1 and DYNLL2 seem
to discriminate binding partners in the cell (6, 19), although
some in vitro studies do not support this finding (21, 24). The
binding grooves are able to interact with short linear se-
quences, all of which are part of intrinsically disordered re-
gions of the partner proteins. These binding motifs were di-
vided into the following three classes based on sequence
similarities: KXTQTX (e.g. Bmf), XG(I/V)QVD (e.g. nNOS),
and noncanonical (e.g.myoVa and Pak1) (2, 14, 25–27). How-
ever, the functional relevance of this classification has never
been investigated. A broad range of affinities of various bind-
ing peptides and protein fragments (Kd values between 100
nM and 100 M), determined by different approaches, were
reported (2, 26, 28–31). However, it is important to note that
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many of the partners were shown to exist as homodimers, and
therefore DYNLL most likely forms dimer-dimer complexes
with its partners (2, 23). Thus, the observed dissociation con-
stants of monomeric peptides may not be used directly to de-
scribe the interaction with dimeric partners, which in fact are
bivalent protein ligands (15). Accordingly, we have previously
reported an affinity enhancement of dimeric myoVa frag-
ments binding to DYNLL2, compared with a monomeric pep-
tide (2), and the same was noted for a dimeric DIC fragment
(26). However, the quantitative relationship between the af-
finity and the monomer-dimer state of the binding partner
was not investigated in previous studies.
Regulation of the interactions of DYNLL as a hub protein is
not well understood. Binding of the partners to DYNLL could
be regulated by phosphorylation of Thr or Ser residues within
the DYNLL-binding motif (32). Phosphorylation of Ser-88 of
DYNLL could be another way of regulation by shifting the
monomer-dimer equilibrium strongly to the monomer state,
thus eliminating the binding grooves (29, 33). It is not clear
which kinase is involved in this regulation; Pak1 was originally
shown to phosphorylate DYNLL (10, 34); however, a recent
study did not support its direct regulatory role (26).
Here, we report the kinetic and thermodynamic parameters
of binding of DYNLL isoforms to various partners with
monovalent and bivalent motifs. We found that the affinity is
dramatically increased by the bivalent nature of the binding
partners. We also found that the binding reaction of both
monovalent and bivalent ligands can be best explained by a
conformational selection model. Furthermore, we show that
ligands can bind to the S88E phosphomimetic form of
DYNLL by pulling the monomer-dimer equilibrium back to
the dimer state.
EXPERIMENTAL PROCEDURES
Expression, Purification, and Synthesis of Proteins and
Peptides—DYNLL2 (amino acid residues 1–89; Uniprot,
Q96FJ2) and the monomeric fragment of myoVa (residues
1275–1297; Q9Y4I1-2) were cloned and expressed as de-
scribed previously (2). The S88E DYNLL2 mutant was gener-
ated by PCR using a mutant oligonucleotide and the wild type
DYNLL2 construct as a template. The dimeric myoVa frag-
ment was constructed by amplifying the myoVa fragment
(residues 1209–1320) by PCR and subsequently fusing coding
sequences of a leucine zipper from a yeast transcription factor
(GCN4; P03069) to the 5 and 3 ends using the megaprimer
method (35). The leucine zippers increase the stability of the
dimers. The PCR product was cloned into pET15b using NdeI
and BglII/BamHI sites. Constructs of DYNLL1 (P63167), Bmf
(Q96LC9), and Pak1 (Q13153) were kind gifts of Drs. I. Ro-
dríguez-Crespo, M. G. Hinds, and R. Kumar, respectively.
DYNLL1 (residues 1–89), Bmf (residues 1–159), and Pak1
(residues 203–268) were amplified by PCR and subcloned into
pET15b (Novagen) vector using NdeI and EcoRI sites. The
dimeric Bmf fragment was created by fusing a leucine zipper
to the 3 end of the sequence corresponding to Bmf residues
64–73. Expression vectors and subcloned protein fragments
used in this work are listed in supplemental Table 1.
Constructs were transformed in BL21-(DE3) Rosetta cells
(Novagen). After induction, cells were grown at 37 °C for 3 h
in 2YT medium. Glutathione S-transferase (GST) fusion and
His-tagged proteins were purified on glutathione-Sepharose
(Amersham Biosciences) and Ni2-affinity columns (Bio-
Rad), respectively. His- and GST-tagged proteins were di-
gested by thrombin. DYNLL1, DYNLL2, DYNLL2 S88E mu-
tant, and the Bmf protein were further purified on a HiTrapQ
ion-exchange column (Amersham Biosciences).
Bmf (TSQEDKATQTL) and nNOS peptides (EMKDT-
GIQVDRDL) were synthesized in-house by solid-phase tech-
niques using an ABI 431A peptide synthesizer and standard
N-(9-fluorenyl)methoxycarbonyl chemistry. N-terminal fluo-
rescein-labeled Bmf peptide was synthesized similarly, except
that before the cleavage step 5(6)-carboxyfluorescein was cou-
pled to the N-terminal amino group. Peptides were further
purified by reverse-phase HPLC on a Jupiter 300 C18 column
(Phenomenex). Concentrations were measured by absorbance
at 280 nm using calculated extinction coefficients or by amino
acid analysis. The identity of each peptide and protein was
confirmed by mass spectrometry.
Isothermal Titration Calorimetry (ITC)—All titrations were
carried out at 299 K in PBS supplied by 3 mM 2-mercaptoeth-
anol (pH 7.4) using a Microcal VP-ITC apparatus. DYNLL1 or
DYNLL2 (in 30 M initial concentration) was titrated up to
5-fold excess of ligands. Depending on the Kd and ligand con-
centration, up to 40 injections were performed with 900-s
time intervals between injections. The measured heat changes
were corrected for dilution effects using data from similar
control experiments. The Origin for ITC 5.0 (OriginLab) soft-
ware package was used for data processing. Several binding
models were tested, but the simplest one site binding (A
B AB) model provided satisfactory results. The errors of the
thermodynamic parameters reported are based on deviations
from the theoretical best fit.
Surface Plasmon Resonance—Surface plasmon resonance
(SPR) experiments were performed on a Biacore 3000 instru-
ment equipped with research grade CM5 sensor chips. Di-
meric myoVa and full-length Bmf (residues 1–159)-coated
surfaces were prepared at 25 °C by the amine-coupling
method. Flow cells were activated for 6 min with a solution
containing 50 mM N-hydroxysuccinimide and 200 mM N-eth-
yl-N-dimethylaminopropylcarbodiimide. Dimeric myoVa
was diluted to 50 g/ml in 10 mM sodium acetate (pH 5.0)
and injected over the surface for 7 min at 10 l/min flow rate.
Excess reactive sites were subsequently blocked by injection
of 35 l of 1 M ethanolamine (pH 8.5). To monitor associa-
tion, various concentrations of DYNLL2 or DYNLL2 S88E in
running buffer (10 mM Hepes (pH 7.4), 0.15 M NaCl, 3 mM
EDTA, and 0.005% Surfactant P20) were applied to either the
ethanolamine blocked control or dimeric myoVa-coated sur-
face at a flow rate of 10 l/min for 15 min and the changes in
the response units were recorded. Dissociation of the com-
plexes was followed for up to 15 min after injection of
DYNLL2 or DYNLL2 S88E free running buffer. The responses
from the surface covered with ethanolamine were subtracted
from the responses obtained with the dimeric myoVa-coated
surfaces. Kinetic (kon and koff) and equilibrium parameters
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(Kd) were derived from the sensograms using BIAevaluation
3.1 software with fitting the data to a simple 1:1 Langmuir
interaction model.
Fluorescence Anisotropy—Fluorescence anisotropy experi-
ments were carried out at 23 °C in PBS supplied by 3 mM
2-mercaptoethanol using an FLS920 spectrofluorometer (Ed-
inburgh Instruments). A CW 450 W xenon arc lamp was used
as a 494-nm excitation source. Anisotropy was recorded at
540 nm. Fluorescein-labeled Bmf peptide was titrated with
DYNLL2 and DYNLL2 S88E (the concentration of Bmf was
held at 818 nM). Anisotropy values were plotted against
DYNLL2 and DYNLL2 S88E concentrations, and the experi-
mental data were fitted using
A  Amin
(Amax Amin)
(Kd, eq [D]0  B0) Kd, eq [D0  B0)2 4D0B0
2B0
(Eq. 1)
where Kd, eq is the dissociation constant; [D]0 is the total con-
centration of DYNLL; [B]0 is the total concentration of fluo-
rescein-labeled Bmf; A is the measured anisotropy of the reac-
tion mixture; and Amin and Amax are the anisotropy values of
the solution when the total amount of fluorescein-labeled Bmf
is free or complexed, respectively.
Stopped-flow Fluorescence Spectroscopy—Tryptophan fluo-
rescence-based transient kinetic measurements were carried
out using a KinTek SF-2004 stopped-flow apparatus. A xenon
light source was used to excite the DYNLL isoforms at 297
nm (4 nm bandwidth). On the emission side, a 340-nm inter-
ference filter was used. Samples were in PBS buffer supplied
by 3 mM 2-mercaptoethanol; the temperature was held at
23 °C. The premix concentration of DYNLL and of the part-
ners were 3 M and between 1 and 1000 M, respectively. The
mixing ratio was 1:1. At least three traces were averaged and
corrected for photobleaching. Double exponentials were fitted
(I A1ekobs1t A2ekobs2t, where I is the fluorescence inten-
sity; A1 and A2 are the amplitudes of the fast and slow phases,
respectively; kobs1 and kobs2 are the observed rate constants of
the fast and slow phases, respectively) to the experimental
data. Detailed data analysis and model fitting were performed
by the KinTek Global Kinetic Explorer 2.2.563 software (36,
37). Data were imported as concentration series with average
and  values of each data point. Two possible minimal models
were constructed and used for analysis (Schemes 1 and 2).
The “induced fit” (IF) model assumes a first binding step fol-
lowed by an isomerization step occurring in the ligand-bound
form. The “conformational selection” (CS) model assumes
that the apoprotein can adopt two states. One of the states
is able to bind to the ligand, but the other one is not. The
two states are in a conformational equilibrium. Binding of
the ligand to the protein pulls the conformational equilib-
rium by consuming the apo-form in the binding-competent
state. Both steps can be associated with a change in fluo-
rescence in both models. Scaling factors were applied to
each trace during the fitting procedure. Multiple attempts
with different initial parameter values were carried out to
find the best fits. Errors on each parameter were estimated
using FitSpace explorer (37) by calculating the lower and
upper bounds (reported in supplemental Table 2). The cal-
culated boundaries reflect fits within 2 multiplied by 1.1
(as suggested in Ref. 37).
RESULTS
Comparison of Binding Properties of DYNLL1 and DYNLL2
Isoforms—Bmf and nNOS are known to bind in vivo to
DYNLL2 (19) and DYNLL1 (5), respectively. They contain
distinct types of DYNLL-binding motifs (Bmf, KATQTD and
nNOS, TGIQVD), suggesting that the DYNLL isoforms could
somehow discriminate between these sequences. To explore
whether this isoform specificity can be detected in vitro, the
thermodynamic and kinetic parameters of the association
reactions were compared for the two pairs of complexes by
ITC and by stopped-flow fluorescence spectroscopy. Al-
though DYNLL1 showed slightly weaker and slower binding
to the peptides than DYNLL2 (e.g. DYNLL1-Bmf, Kd, eq1
M, konC  10.4 mM1 s1; DYNLL2-Bmf, Kd, eq0.7 M,
konC  21.7 mM1 s1), both peptides were able to bind to
both isoforms with rather similar dissociation constants (Ta-
ble 1 and Fig. 1; see below for detailed explanation of the ki-
netic analysis). Therefore, if isoform-specific target selection
exists in vivo, one should assume the existence of additional
“specificity-determining” factors. Because of the in vitro simi-
larity of the two isoforms, only DYNLL2 was used hereafter in
all measurements.
Comparison of Various DYNLL-binding Motifs—The high
diversity observed among the DYNLL-binding motifs suggests
that in the cell, where several interacting partners could be
present at the same time and therefore compete for a com-
mon groove on DYNLL, the different dissociation constants
together with the local concentrations of the partners would
determine the distribution of DYNLL among the interacting
proteins. Thermodynamic parameters and kinetic constants
of complex formation were determined by ITC and stopped-
flow measurements, respectively (Table 1 and Figs. 1 and 4).
The consensus class 1 type Bmf peptide (KATQTL) inter-
acted with the highest affinity (Kd, eq 0.7 M) with DYNLL2.
The nNOS peptide (TGIQVD) representing class 2 consensus
motif bound somewhat weaker (Kd, eq5 M), whereas the
noncanonical myoVa peptide (KNTMTD) has almost the
same affinity as the nNOS peptide (Kd, eq9 M). The most
divergent sequence from the consensus motifs in Pak1
(VATSPI) has the lowest affinity (Kd, eq40 M). Interest-
ingly, the association of DYNLL2 to nNOS, myoVa, and Pak1
is favorable both entropically and enthalpically, whereas the
interaction with Bmf is enthalpy-driven and entropically dis-
favored. Accordingly, the free energy of binding of Bmf to
DYNLL2 has a higher contribution from enthalpy change
SCHEME 1. Induced fit model. SCHEME 2. Conformational selectionmodel.
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(50 kJ/mol) than those of other partners. The association
rate constants of the peptides are in the range of 6–58
mM1s1. The off-rates of the complexes are between 0.1 and
0.6 s1 for nNOS, myoVa, and Pak1. Interestingly, the off-rate
constant of Bmf is about 100 times lower (	0.002 s1). Our
conclusion is that the two putative classes of motifs can bind
to DYNLL2 with similar strength but with different interac-
tion patterns and mechanism.
We also determined the binding properties of an almost
full-length Bmf polypeptide (residues 1–159), missing only
the C-terminal highly hydrophobic putative membrane an-
chor (38) to DYNLL2 by SPR and found only little differences
(Kd, eq4 M) compared with the Bmf peptide (Kd, eq0.7
M). This result confirms that the short linear binding motif
is the only determinant of the binding affinity, and no second-
ary DYNLL-binding site is present, at least on Bmf.
Dimeric State of the Interacting Partners Considerably In-
creases Affinity to DYNLL—Most binding partners of DYNLL
(myoVa, DIC, swallow, and nNOS) exist as homodimers.
Moreover, DYNLL promotes dimerization as was observed
with swallow, DIC, and myoVa (2, 15, 23, 39). Hence, it is im-
portant to characterize dimer-to-dimer interactions of
DYNLL complexes to get more insight into their biological
role. To collect relevant data, we compared the kinetic and
thermodynamic properties of monomeric (monovalent li-
gand) and dimeric (bivalent ligand) forms of two partners
(Table 1). First, we investigated the in vitro binding properties
of DYNLL2 and a stable dimeric fragment of myoVa. We have
previously shown that a similar myoVa fragment with only
one Leu zipper at the N-terminal end has a dimerization Kd of
	30 nM (3). A monomeric peptide corresponding to the mini-
mal DYNLL-binding motif of myoVa was used as a control.
ITC measurements showed that the stoichiometry of the
complexes was 1:1 (dimer to dimer) and 2:1 (two monomers
to a dimer) for the dimeric and monomeric myoVa construct,
respectively. The dimeric fragment has an	250-fold stronger
affinity to DYNLL2 (Kd, eq40 nM) relative to the monomeric
one (Kd, eq9 M). This effect is most likely the consequence
of avidity, but other causes, such as the contribution of a sec-
ondary DYNLL-binding site on the myoVa fragment, cannot
be completely ruled out. To analyze directly the contribution
of avidity to the affinity increase, an artificial dimeric DYNLL-
binding sequence, a Leu zipper dimerized Bmf motif (con-
nected by a six-residue linker) was constructed and compared
with the monomeric Bmf peptide (Table 1 and Fig. 1). The
observed increase in affinity was similar (	200-fold, Kd, eq 3
nM) to that of myoVa. These results confirm that the en-
hanced affinity of dimeric partner binding to DYNLL can be
achieved by avidity effect.
Affinity enhancement by avidity could be attributed to the
decrease in the observed off-rate constants with almost un-
changed on-rate constants (40–43). To investigate this as-
sumption, we first determined the rate constants by stopped-
flow fluorescence spectroscopy (Table 1 and supplemental
Table 2). Binding of the dimeric myoVa was also measured by
SPR because its high affinity to DYNLL prevented determina-
tion of the koff values with sufficient accuracy by the stopped-
flow method (Table 2 and Fig. 2). The results indicate that the
off-rate constant of dimeric myoVa is	450-fold lower than
that of monomeric myoVa, although less than 2-fold decrease
was detected in the on-rate constant (Table 1).
Binding Properties of the S88E DYNLL2 Mutant—It has
been previously shown that phosphorylation of DYNLL at
Ser-88 could inhibit partner binding (10) by promoting disso-
ciation of DYNLL dimers to monomers (29, 33). The mono-
mer-dimer equilibrium of the phosphomimetic DYNLL2
S88E mutant is strongly shifted toward the monomer state
(29, 33). Binding affinities of the wild type and the mutant
DYNLL2 were determined using a fluorescein-labeled peptide
corresponding to the binding motif of Bmf by a fluorescence
anisotropy titration assay (Table 2 and Fig. 3). The observed
Kd value of the S88E mutant was 30-fold weaker (110 M)
TABLE 1
Thermodynamic and kinetic parameters of DYNLL binding to various partners
Partner Isoform Kd, eqa Ha TSa konC b koffC b
nM kJ mol1 kJ mol1 M 1 s1 s1
Bmf (DKATQTL) DYNLL1 1050
 40 46.1
 0.2 11.9 10400 –c
Bmf (DKATQTL) DYNLL2 735
 22 51.3
 0.1 16.1 21700 –c
Bmf (dimeric) DYNLL2 3.46
 0.46 81.1
 0.1 32.7 13000 –c
nNOS (DTGIQVD) DYNLL1 7000
 230 18.7
 0.1 10.8 46800 4.22 101
nNOS (DTGIQVD) DYNLL2 5410
 150 22.3
 0.1 7.91 58400 4.37 101
Myosin Va (DKNTMTD) DYNLL2 8850
 670 23.9
 0.4 4.93 6590 1.03 101
Myosin Va (dimeric) DYNLL2 37
 5 28.5
 0.1 13.9 4020 –c
Pak1 (DVATSPI) DYNLL2 42700
 5300 21.5
 4.1 3.48 16400 6.41 101
a Kd, eq, H, andTS values were calculated from ITC measurements (Fig. 1). Errors are the standard error of fitting.
b konC and koffC were calculated from stopped-flow experiments (Fig. 4 and supplemental Fig. 2).
c The koffC values for dimeric binding and high affinity binding of monomeric Bmf could not be determined with sufficient accuracy. The standard error of konC and koffC values
and more detailed kinetic data can be found in supplemental Table 2.
FIGURE 1. Thermodynamic data showingmonomeric or dimeric Bmf
fragment binding to DYNLL isoforms. Heat changes were recorded in ITC
experiments upon titration of DYNLL1 (A) and DYNLL2 (B) with a mono-
meric Bmf fragment. In both cases, the dissociation constants (0.74 and 1.05
M, respectively), the entropy change, and the enthalpy change were very
similar (see Table 1). C, dimeric Bmf fragment (Kd 3.5 nM) showed	200-
fold stronger binding to DYNLL2 than the monomeric Bmf.
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than that of wild type DYNLL2 (	3.5 M). Such a weak inter-
action probably does not have any physiological significance.
The dimeric nature of the binding partners causes avidity, and
this could affect the observed affinity to the S88E mutant as
well. This hypothesis was tested by SPR and an immobilized
dimeric myoVa fragment as a model (Table 2 and Fig. 2).
The calculated dissociation constants for wild type and
S88E mutant DYNLL2 were 50 nM and 2.7 M, respectively. It
is noteworthy that the	50-fold weaker Kd value in case of the
mutant mainly resulted from a change in the observed on-rate
constant, whereas the off-rate constant was almost un-
changed. The monomeric form of the S88E mutant is unable
to bind its partners because the binding groove formation is
coupled to dimerization (29, 33). Because only the dimeric
DYNLL is functional in binding, complex formation depletes
the small amount of dimers in equilibrium with monomers in
the mutant. Therefore, the monomer-dimer equilibrium is
pulled toward dimers. In the case of the S88E mutant, the low
observed kon value probably results from a very low degree of
dimer formation at the applied concentration.
Two-step Binding Kinetics—A single buried tryptophan res-
idue (Trp-54) is found in each DYNLL monomer that re-
sponds to ligand binding. On rapid mixing of DYNLL2 with
ligands using a stopped-flow apparatus, biphasic binding tran-
sients were observed (Fig. 4A and supplemental Fig. 1). In
double exponential fits to traces recorded under pseudo first-
order conditions, the observed rate constants of the fast phase
(kobs1) showed linear dependence on peptide ligand concen-
tration (Fig. 4B), whereas the observed rate constants of the
slow phase (kobs2) were in all cases in the same range (0.01–
0.05 s1) with no obvious concentration dependence (Fig.
4C). This suggests that the observed fluorescence changes
arose from a combination of a second-order association and a
first-order step, a conformational change of either ligand-free
or ligand-bound DYNLL2. Under pseudo first-order condi-
tions,	70% of the total amplitude change came from the first
phase and	30% from the second phase (Fig. 4D).
Besides the exponential approximations, experimental data
were also fitted globally using the two possible minimal mod-
els, IF and CS (see under “Experimental Procedures”). De-
tailed parameters obtained by either models can be found in
supplemental Table 2. Generally, the kinetic parameters of
binding could be determined with acceptable quality. The
parameters of the isomerization steps were less reliable.
Regarding the high affinity binding of dimers or Bmf, the
koff value of binding was uncertain (see the error values in
supplemental Table 2). The rate constants of the binding steps
determined by either the IF and CSmodels had similar values,
which also indicates that these values are well constrained by the
data, and the uncertainties of the isomerization stepmay have
little effect on the determined parameters of the binding step.
The kinetic parameters reported in this work (Table 1) are
those obtained using the CS model, which provided slightly
better fitting than the IF model. Kd, eq values were robustly
determined by our ITC experiments (Table 1 and Fig. 1). The
overall dissociation constants were also calculated from the IF
model as shown in Equation 3,
Kd, eq  1(Kb1 Ki) (Eq. 3)
FIGURE 2. SPRmeasurements. SPR assay was used to investigate the inter-
action between the dimeric myoVa and DYNLL2 (A) or DYNLL2 S88E (B). The
dimeric myoVa was immobilized on CM5 sensor chip. 10, 5, 2, 1, 0.5, 0.1M
and 20, 17.5, 15, 12.5, 10, 7.5, and 5 M concentrations of DYNLL2 and
DYNLL2 S88E, respectively, were used to monitor the association and disso-
ciation. Data were analyzed with simple 1:1 Langmuir interaction model.
Similar observed off-rate constants were obtained with the two DYNLL2
constructs (DYNLL2 S88E, 3.41 104
 4.5 105 s1; WT, 2.24 104

1.0 105 s1), although the observed on-rate constant of the DYNLL2
S88E (147
 64 M1s1) was much smaller than the observed on-rate con-
stant of the WT DYNLL2 (4840
 1290 M1s1).
FIGURE 3. Fluorescence anisotropymeasurements of Bmf peptide bind-
ing to DYNLL2 and DYNLL2 S88E. Fluorescein-labeled Bmf peptide was
titrated with increasing concentrations of DYNLL2 (f) and DYNLL2 S88E
mutant (Œ). The inset contains the same DYNLL2 titration data (f) in the
lower concentration range. Fluorescein was excited at 494 nm, and the ani-
sotropy was monitored at 540 nm. The concentration of fluorescein-labeled
Bmf peptide was held at 818 nM. In the case of DYNLL2 the observed disso-
ciation constant was 3.58
 0.4 M, although DYNLL2 S88E showed much
weaker binding (Kd 110
 20 M).
TABLE 2
Comparison of the binding of wild type andmonomeric mutant DYNLL2 to monomeric and dimeric partners
Sample Partner Kd kona koffa
nM M 1 s1 s1
DYNLL2 Bmf 3580
 400b
DYNLL2 S88E Bmf 110,000
 20,000b
DYNLL2 Dimeric myoVa 50.0
 14.7a 4840
 1290 2.24 104
 1.0 105
DYNLL2 S88E dimeric myoVa 2690
 860a 147
 64 3.41 104
 4.5 105
a Data were calculated from SPR measurements (Fig. 2).
b Data were determined by fluorescence anisotropy titration assay (Fig. 3).
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and also from the CS model shown in Equation 4,
Kd, eq  (1 Ki)KbKi (Eq. 4)
where Kb kon/koff and Ki ki/k i (supplemental Table 2).
The obtained Kd, eq values were in line with those determined
by ITC measurements except the high affinity partners where
the off-rate constants were not reliable by the stopped-flow
method.
DISCUSSION
DYNLL Isoforms Have Similar Binding Properties to Their
Various Targets—To understand the robust interactome of
the cell, it is important to characterize and quantify individual
protein-protein interactions. In this study, we have described
the binding properties of the LC8 dynein light chain hub pro-
tein to various binding partners. The ubiquitous eukaryotic
DYNLL has two mammalian paralogs, DYNLL1 and DYN-
LLL2, with 93% sequence similarity. In a previous study, Bim
and Bmf, two pro-apoptotic proteins sharing similar KX-
TQTX type DYNLL-binding motifs, were found in vivo to be
associated exclusively with DYNLL1 and DYNLL2, respec-
tively (6, 7); however in an in vitro GST pulldown assay, no
discrimination was observed (19). On the other hand, nNOS
having a XG(I/V)QTD motif is a known binding partner of
DYNLL1 only (5). Here, we quantitatively compared the bind-
ing properties of the two DYNLL isoforms to the two distinct
types of binding motifs (XG(I/V)QVD in nNOS and KXTQTX
in Bmf) in vitro. Only small differences in affinities were ob-
served, which cannot explain the in vivo observed partner
specificities. It is likely that other factors or proteins mediate
the specificity and distinct cellular localization of DYNLL iso-
forms. The six-residue differences between the two paralogs
are located on the external surface of DYNLL homodimers,
and they might be part of a potential recognition site for the
yet unidentified specificity determining protein(s). Day et al.
(19) found that His-41 and Tyr-41 on the surface of DYNLL1
and DYNLL2, respectively, determine the specific localization
of the isoforms to their respective cytoskeletal structures. Fu-
ture studies are needed to clarify the structural basis of in vivo
isoform specificity of DYNLL binding partners.
Fine-tuning of Affinities Is Achieved through Diversity of
Binding Motifs—The linear DYNLL-binding motifs were orig-
inally divided into two classes, XG(I/V)QVD and KXTQTX
(44). The most conserved position is the Gln, which is gener-
ally in the vicinity of Thr or Ile/Val residues (19, 45). It is im-
portant to note that mixed sequences (IQT in p53BP1 and
VQT in Nup159) can be found in several DYNLL-binding
motifs. Moreover, there are at least two motifs that lack the
FIGURE 4. Tryptophan fluorescence-based transient kinetic measurements. A, fluorescence change of Trp-54 in DYNLL isoforms was monitored follow-
ing rapid mixing of DYNLL (3 M monomer concentration (Conc)) with different peptides at a series of peptide concentrations (post-mixing concentrations
indicated). Trp-54 was selectively excited at 297 nm, and the emission was monitored at 340 nm. Biphasic binding transients were observed. The reactions
of nNOS with DYNLL1 are shown. Curves represent global best-fits based on the conformational selection model, fitted by Kintek Explorer Pro software. B, as
an alternative to global fit analysis, double exponential approximations to the recorded transients were also applied. In this analysis, the determined kobs1
(fast phase observed rate constant) values showed linear dependence on peptide concentration under pseudo first-order conditions, as exemplified by the
Bmf-LeuZ data. (Linear fitting was performed by weighting each data point with the associated standard error.) C, kobs2 (slow phase observed rate constant)
values were in a narrow range (0.01–0.06) in every experiment and showed no obvious dependence on the peptide concentration. D, under pseudo first-
order conditions, the fractional amplitudes of the fast (A1) and slow (A2) phases were around 70 and 30%, respectively. (The vertical black lines in B–D repre-
sent a practical lower limit of pseudo first-order conditions) (DYNLL2/BmF-LeuZ concentration ratio of 1:5).
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central Gln, myoVa, and Pak1; the myoVa sequence (KNT-
MTD) is otherwise more similar to the KXTQTX consensus,
whereas the Pak1 sequence (VATSPI) is clearly a noncanoni-
cal one. We compared the dissociation constants of repre-
sentative sequences from the two putative canonical classes
and the two noncanonical sequences to DYNLL2, and we
found relatively small differences (Table 2). This narrow
range of affinities could hardly determine the specific binding
of DYNLL2 when more partners are present simultaneously.
The hierarchy of binding affinities proposed in a previous
study (26) is corroborated by our data except that myoVa
binds five times stronger than Pak1. We conclude that there is
a continuum of binding affinities of the various partners irre-
spective of the putative type of motifs. However, the binding
mechanisms of the various classes seem to be different. Bind-
ing of the KXTQTXmotif was found to be enthalpically fa-
vored and entropically disfavored, whereas the motifs from
the other class or having noncanonical sequence (myoVa and
Pak1) are both enthalpy- and entropy-driven (28). Moreover,
the KXTQTXmotif has a lower off-rate constant than the
other class. It is not yet clear whether there is any biological
relevance of the different binding mechanisms.
Barbar and co-workers (17) proposed that positive cooper-
ativity between the two ligand-binding sites of DYNLL could
be a mechanism to promote simultaneous binding of ligands
containing the same motif. This could be one factor for deter-
mining optimal binding strength and specificity. However,
our results suggest that, in agreement with the previous quali-
tative data of Williams et al. (15, 26), the dimer state of the
partners and hence avidity is more important in this respect
(see below). Differences in binding motifs may thus be a “fine-
tuning mechanism” in the interaction network of DYNLL.
Importance of Avidity, Several Hundredfold Stronger Bind-
ing to Dimer Partners of DYNLL—To understand the interac-
tion between dimeric DYNLL and dimeric partners, several
factors should be taken into account, including coupled equi-
libria, such as the monomer-dimer equilibrium of DYNLL.
The dimer stability of DYNLL was found to be submicromo-
lar (26). Because DYNLL is predominantly dimeric under
physiological conditions, and targets are able to bind only to
dimeric DYNLL, the monomer-dimer equilibrium affects li-
gand binding only if it is strongly shifted by a regulatory signal
(e.g. reversible phosphorylation). Another important factor
could be the above-mentioned cooperativity of the two
DYNLL-binding sites; however, our ITC and stopped-flow
data can be well explained without the incorporation of coop-
erativity into the models. Therefore, we analyzed all data in
this work by the simplifying assumption that ligand binding to
the two grooves at the opposite sides of a DYNLL dimer is
independent. The third factor to be taken into account is the
stoichiometry of the complexes. We observed a 1:1 (dimer-to-
dimer) stoichiometry in case of a complex of dimeric myoVa
fragment and DYNLL2 by ITC measurement. The same stoi-
chiometry was found by others in the case of isolated chick
brain full-length myoVa (46) and in Tctex-DIC-DYNLL crys-
tal structure (15).
The affinity enhancement phenomenon caused by dimer-
ization is called avidity. It has been widely studied in antibod-
ies but less studied in other protein-protein interactions (47).
It was observed in the complex of DYNLL with a dimeric DIC
fragment, but only qualitatively analyzed (15). In this study,
we compared the affinities of two pairs of monomeric and
dimeric DYNLL-binding motifs (of myoVa and Bmf) and
found200-fold affinity enhancement in both cases. In case
of a myoVa dimer, kinetic analysis by stopped-flow and SPR
measurements showed that the increased affinity is due to a
decreased rate of dissociation of the complex in line with the
avidity hypothesis (47). The avidity effect could explain the
previously described wide range of binding affinities (100 nM
to 100 M) determined for either monomeric or dimeric li-
gands (2, 26, 28–31, 33).
Dimer to Monomer Transition of DYNLL Could Be an Effec-
tive Way of Regulation—DYNLL2 monomers are structurally
incapable of binding to their partners, even though complex
formation was observed in this work at very high concentra-
tions of a monomeric partner (Kd110 M). Dimeric myoVa
showed an	50 times higher apparent affinity indicating the
presence of avidity effect with the S88E mutant. In this case,
the observed Kd values is in the same range as that of the wild
type DYNLL with monomeric ligand. As ligands bind only to
DYNLL dimers (a strong assumption), Le Chatelier’s principle
shifts the monomer-dimer equilibrium toward dimer forma-
tion. Detailed thermodynamic analysis of the S88E mutant
interactions has not been attempted. The dissociation con-
stant of the S88E mutant dimer was determined by Barbar
and co-workers (48) using NMR titration and reported to be
1 mM. These results are consistent with the hypothesis that
control of the monomer-dimer equilibrium of DYNLL could
have a regulatory role by strongly affecting target selection.
Under physiological conditions monomeric DYNLL2 could
bind, although with diminished apparent affinity, to dimeric
partners that locally have high concentration; however, they
would not interact with monomeric partners.
In an in vitro study, weak or no interaction was found be-
tween the phosphomimetic S88E mutant and Bim or Pak1
(29). Others were able to detect relatively strong interactions
in case of the DIC and swallow (33). Recently, a phosphomi-
metic S90E mutant of Chlamydomonas flagella LC8, which is
analogous to the human DYNLL S88E mutant, was found to
be largely monomeric in vitro but dimeric in vivo. This muta-
tion did not cause significant change in flagellar generation
and motility (49). The crystal structure of a homologous
phosphomimetic DYNLL mutant bound to a fragment of
swallow has also been determined (48). The mutant was di-
meric in this complex, and its structure was largely identical
to that of wild type DYNLL-swallow complex (48).
It is still not clear which kinase phosphorylates the verte-
brate DYNLL isoforms in vivo. Previous studies showed that
Pak1 not only binds to but also phosphorylates DYNLL1 (10,
34). However, a recent study questioned the regulatory role of
Pak1 (26). We confirmed in this work that Pak1 was unable to
phosphorylate DYNLL1 and DYNLL2 in an in vitro assay;
instead, it most likely phosphorylated a thrombin recognition
site in the recombinant His-tagged proteins (supplemental
Fig. 2). It is now concluded that Pak1 is not involved directly
in regulation of the DYNLL interaction network, and Ser-88
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must be phosphorylated in the cell by a yet unidentified ki-
nase. Nevertheless, it is clear the phosphorylation of Ser-88
will affect DYNLL binding to its targets and could provide an
effective way of regulation.
Binding of Ligands to DYNLL Occurs in Two Steps—In this
work, we report the first kinetic analysis of the binding reac-
tions of mono- and bivalent ligands to DYNLL. Two-phase
binding was observed in all cases, irrespective of the valence
of the ligands. Two possible minimal models, the IF or the CS
can be used to describe this behavior of the system.
Structures of both apo-DYNLL (17) and several DYNLL-
peptide complexes have been determined by x-ray crystallog-
raphy (13, 15, 16). Comparison of these structures revealed a
ligand-dependent widening of the binding grooves by	1 Å
for KXTQTX (swallow) ligands and by	2 Å for XG(I/V)QVD
(nNOS) ligands (17). Therefore, the conformational change of
DYNLL must be an important requirement for ligand bind-
ing. However, these structures provide no information on the
order of the ligand binding and the conformational change.
Backbone dynamics of DYNLL and DYNLL-peptide com-
plexes were investigated by 15N NMR relaxation experiments,
both in the apo- and ligand-bound forms (50, 51). The amino
acid residues of the target-binding grooves of apo-DYNLL
displayed conformational exchanges on the millisecond-to-
microsecond time scale. The existence of slow time scale ex-
changes was also indicated by backbone amide hydrogen-
deuterium exchange studies (50, 51). However, these
experiments are probing conformational exchange at a min-
utes-to-hours time scale. The alternative (dynamic) confor-
mations were suggested to be responsible for the ability of
DYNLL to bind to diverse targets. Similar experiments with
DYNLL-peptide complexes indicated that although the over-
all backbone dynamics of DYNLL remains largely unchanged,
the conformational breathing of the partner binding groove is
significantly reduced in the complex. However, some parts of
DYNLL showed flexibility even after complex formation (50).
More recent results showed that the degree of structural or-
dering of DYNLL upon partner binding was ligand-dependent
and correlates with the entropy change of the binding reac-
tion (28). There was only a minimal change found in back-
bone dynamics relative to apo-DYNLL if ligand binding was
entropically favored. Entropically disfavored binding was con-
sistent with higher ordering of DYNLL in the complex (28).
These results also confirm that there is a difference in the
binding mechanism of the different classes of motifs. The
presence of increased conformational motions of DYNLL in
the apo-form compared with that in the DYNLL-ligand com-
plex revealed by the NMR experiments is consistent with our
CS model. Moreover, in stopped-flow experiments, based on
the comparison of 2/degrees of freedom values, slightly bet-
ter fits were obtained in almost every case using the CS
model, and the three-dimensional confidence contour plots
also indicated a better fit (supplemental Fig. 3). Therefore, we
assume that DYNLL-ligand binding occurs via the CS mecha-
nism. A similar binding mechanism has been demonstrated
for ubiquitin and its target proteins (52). Finally, it must be
noted that, based on our data, the existence of more complex
reaction schemes (like the combination of IF and CS) cannot
be ruled out.
Physiological Relevance of the Thermodynamic and Kinetic
Fine-tuning of the DYNLL Interaction Network—What is the
functional significance of avidity? In general, the binding af-
finity and specificity are significantly enhanced. Based on our
quantitative analysis of complex formation of representative
members of the DYNLL binding partners as monovalent and
bivalent ligands, it is likely that at physiological protein con-
centrations (mostly submicromolar to micromolar in range)
(53) the DYNLL-binding sites would be saturated only by di-
meric interacting proteins. Indeed, most of the known bind-
ing partners of DYNLL are either dimeric or promoted to
form dimers upon DYNLL binding by physically holding the
two interacting polypeptide chains close to each other (54).
Higher apparent affinity of DYNLL binding to dimeric protein
fragments was first noted by studying DYNLL2 and myoVa
interactions (2) and later attributed to avidity (15). This hy-
pothesis questioned the original proposal of heterodimeric
cargo adapter role of DYNLL on dynein and myoVa motor
complexes (6, 7, 21, 55–58).
Among the DYNLL binding partners, only Bim and Bmf
were reported so far to be monomeric (59). However, one can
speculate that their hydrophobic C-terminal part might func-
tion as a membrane-anchoring site (38), and therefore, they
can behave as a “quasi-bivalent” ligand for DYNLL to utilize
avidity to increase binding affinity on the surface of mem-
branes. Interestingly, the KXTQTXmotif of Bmf showed
strikingly slower dissociation than other motifs (koffC 103, in
contrast to koffC 101). The apparent koffC value of a DYNLL-
dimeric partner interaction can be low due to the avidity ef-
fect, so the resulting complexes can have a longer lifetime in
the cell, where this kind of stability might be an important
requirement for their function. It is possible that the sequence
of Bmf has been evolutionarily optimized for lower koffC values,
because Bmf is not dimeric. The kinetic difference between
the KXTQTX and other DYNLL-binding motif classes seems
to be an important feature, but it is also possible that the slow
off-rate is a specific property of pro-apoptotic proteins within
this class.
In conclusion, we propose that the two distinguishable ki-
netic and thermodynamic mechanisms of complex formation
(KXTQTXmotif and others motif classes) represent a fine-
tuning mechanism in the interaction network of DYNLL. The
low off-rate of the bivalent binding of dimers and hence lon-
ger lifetime of the complexes could be ideal for DYNLL to
function as a dimerization and/or sequestration hub protein
that is also involved in formation of supramolecular
structures.
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Supplemental Information 
 
 
Supplemental Table 1: Subcloned protein fragments and expression vectors used in this work 
Name Swiss-Prot entry Residues Vector Enzyme 
dynein light chain 1 (DYNLL1) P63167 1-89 pET15b NdeI, EcoRI 
dynein light chain 2 (DYNLL2) Q96FJ2 1-89 pET15b NdeI, EcoRI 
dynein light chain 2 Ser88Glu (DYNLL2 S88E) Q96FJ2 1-89 pET15b NdeI, EcoRI 
monomeric myosin Va Q9Y4I1 1275-1297 pGEX4T-1 BamHI, EcoRI 
dimeric myosin Va * Q9Y4I1 1209-1320 pET15b NdeI, BamHI/BglII 
Bcl-2-modifying factor (Bmf) Q96LC9 1-159 pET15b NdeI, EcoRI 
dimeric Bcl-2-modifying factor (Bmf-Leu-Z)** Q96LC9 64-73 pET15b NdeI, BamHI/BglII 
p21-activated kinase 1 (Pak1) Q13153 203-268 pET15b NdeI, EcoRI 
 
*The coding sequence of myoVa fragment (residues: 1209-1320) was amplified by PCR and subsequently the sequence corresponding to a leucine zipper was 
fused to the 5’ and 3’ ends using the megaprimer method (GCN4 residues 250-278 to the N-terminus and GCN4 residues 255-281 to the C-terminus). 
**The dimeric Bmf fragment was created by using long, synthetic oligonucleotide containing the coding region of Bmf residues 64-73 followed by six triplets 
corresponding to a six-residue linker (GGSGGS). The coding region of the leucine zipper of GCN4 (residues 250-281) was amplified by using this 5’ 
oligonucleotide. The PCR product was cloned into pET15b using NdeI and BglII/BamHI sites. 
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Supplemental Table 2: Comparison of the kinetic constants obtained by using the Conformational Selection (CS) or Induced Fit (IF) 
models*. 
Conformational Selection model
Partner Isoform kC+i (s-1) StdErr kC-i (s-1) StdErr kCon (µM-1s-1) StdErr kCoff (s-1) StdErr f1 StdErr f2 StdErr f3 StdErr KCB (nM-1) KCi KdCB (nM) KdCi KeqC (nM-1) KdeqC (nM) Kdeq (nM) (ITC)
Upper Bound 6.06E-03 4.48E-03 1.12E-02 3.66E-03 5.85E-02 5.62E-02 6.50E-02
Bmf DYNLL1 Best Fit 4.26E-03 9.28E-02 2.35E-04 2.15E-04 1.04E-02 2.08E-03 2.92E-03 1.25E-03 1.34E-02 4.52E-02 5.60E-02 5.11E-04 6.47E-02 4.66E-05 3.6E-03 18.1 281 5.5E-02 3.4E-03 297 1050
Lower Bound 3.41E-03 1.88E-04 9.33E-03 1.35E-03 5.61E-04 4.91E-02 6.44E-02
Upper Bound 1.66E-02 8.99E-03 2.39E-02 2.90E-03 8.84E-02 8.70E-02 9.83E-02
Bmf DYNLL2 Best Fit 1.24E-02 6.60E-02 9.35E-04 2.17E-03 2.17E-02 3.96E-03 1.85E-03 4.20E-03 4.15E-02 7.44E-02 8.68E-02 1.19E-03 9.80E-02 1.18E-04 1.2E-02 13.3 85 7.5E-02 1.1E-02 92 735
Lower Bound 9.93E-03 5.99E-04 2.06E-02 7.90E-04 2.53E-02 8.02E-02 9.78E-02
Upper Bound 1.82E-02 1.08E-02 1.38E-02 1.86E-03 1.02E-01 9.95E-02 1.14E-01
dimeric Bmf DYNLL2 Best Fit 1.54E-02 1.61E-02 6.44E-03 4.44E-03 1.30E-02 1.12E-03 1.13E-03 1.43E-03 9.73E-02 1.67E-03 9.48E-02 8.10E-04 1.14E-01 7.19E-05 1.2E-02 2.4 87 4.2E-01 8.1E-03 123 3
Lower Bound 1.03E-02 6.92E-04 1.17E-02 7.25E-04 3.86E-02 9.13E-02 1.14E-01
Upper Bound 1.12E-02 2.17E-03 5.85E-02 5.28E-01 4.55E-02 5.32E-02 6.03E-02
nNOS DYNLL1 Best Fit 8.92E-03 6.98E-02 7.09E-04 3.50E-04 4.68E-02 8.01E-03 4.22E-01 3.74E-02 2.60E-02 2.02E-02 5.30E-02 4.02E-04 6.01E-02 4.84E-05 1.1E-04 12.6 9025 8.0E-02 1.0E-04 9743 7000
Lower Bound 6.77E-03 3.63E-04 3.52E-02 3.10E-01 8.27E-03 5.22E-02 6.00E-02
Upper Bound 1.77E-02 7.58E-03 8.24E-02 6.26E-01 9.15E-02 9.44E-02 1.07E-01
nNOS DYNLL2 Best Fit 1.59E-02 2.06E-02 3.86E-03 1.69E-03 5.84E-02 7.44E-03 4.37E-01 3.84E-02 8.34E-02 4.31E-03 9.31E-02 6.52E-04 1.07E-01 5.02E-05 1.3E-04 4.1 7485 2.4E-01 1.1E-04 9297 5410
Lower Bound 1.48E-02 1.58E-03 4.62E-02 3.39E-01 6.00E-02 9.11E-02 1.07E-01
Upper Bound 2.06E-02 2.13E-02 7.30E-03 1.17E-01 1.06E-01 1.04E-01 1.16E-01
myosin Va DYNLL2 Best Fit 1.93E-02 1.95E-02 8.35E-03 3.71E-03 6.59E-03 2.91E-03 1.03E-01 9.11E-03 9.91E-02 2.92E-03 1.02E-01 1.03E-03 1.16E-01 8.59E-05 6.4E-05 2.3 15607 4.3E-01 4.5E-05 22362 8850
Lower Bound 1.71E-02 4.27E-03 5.53E-03 6.16E-02 9.05E-02 9.59E-02 1.16E-01
Upper Bound 1.59E-02 5.84E-03 4.62E-03 9.75E-04 9.41E-02 9.74E-02 1.09E-01
dimeric myosin Va DYNLL2 Best Fit 1.08E-02 7.81E-02 9.79E-04 1.06E-03 4.02E-03 1.48E-03 7.38E-04 6.21E-04 5.98E-02 2.60E-02 9.72E-02 7.55E-04 1.08E-01 8.39E-05 5.4E-03 11.0 184 9.1E-02 5.0E-03 200 37
Lower Bound 8.53E-03 5.01E-04 3.82E-03 2.38E-04 3.85E-02 9.40E-02 1.08E-01
Upper Bound 3.50E-02 7.20E-03 1.86E-02 7.29E-01 9.73E-02 1.07E-01 1.25E-01
Pak1 DYNLL2 Best Fit 2.80E-02 3.85E-02 3.69E-03 3.75E-03 1.64E-02 2.68E-03 6.41E-01 4.78E-02 8.11E-02 1.42E-02 1.06E-01 8.44E-04 1.24E-01 3.84E-04 2.6E-05 7.6 39095 1.3E-01 2.3E-05 44240 42700
Lower Bound 2.24E-02 1.21E-03 1.31E-02 5.12E-01 3.58E-02 1.05E-01 1.24E-01
Induced fit model
Partner Isoform kIon (µM-1s-1) StdErr kIoff (s-1) StdErr kI+i (s-1) StdErr kI-i (s-1) StdErr f1 StdErr f2 StdErr f3 StdErr KIB (nM-1) KIi KdIB (nM) KdIi KeqI (nM-1) KdeqI (nM) Kdeq (nM) (ITC) 
Upper Bound 1.17E-02 3.57E-03 1.18E-03 6.16E-03 5.41E-02 6.22E-02 4.23E-01
Bmf DYNLL1 Best Fit 1.06E-02 2.09E-03 2.58E-03 7.88E-04 4.15E-05 1.95E-05 4.67E-03 1.27E-01 5.39E-02 1.00E-04 6.20E-02 1.18E-04 3.59E-01 4.46E-01 4.1E-03 8.9E-03 243 1.1E+02 4.1E-03 245 1050
Lower Bound 9.47E-03 2.06E-03 2.70E-05 2.46E-03 5.38E-02 6.19E-02 7.06E-02
Upper Bound 2.36E-02 5.81E-03 1.20E-02 1.65E-02 8.38E-02 9.42E-02 2.29E+00
Bmf DYNLL2 Best Fit 2.21E-02 3.93E-03 2.03E-03 1.93E-03 7.62E-04 4.16E-04 1.14E-02 1.17E-01 8.36E-02 1.62E-04 9.41E-02 2.23E-04 1.58E-01 8.49E-02 1.1E-02 6.7E-02 92 1.5E+01 1.0E-02 98 735
Lower Bound 1.97E-02 1.30E-03 3.01E-05 3.31E-03 8.36E-02 9.39E-02 9.89E-02
Upper Bound 1.37E-02 7.74E-03 1.32E-02 9.52E-03 9.57E-02 1.09E-01 1.31E-01
dimeric Bmf DYNLL2 Best Fit 1.28E-02 1.17E-03 4.67E-03 1.50E-03 8.44E-03 2.93E-03 4.95E-03 9.20E-03 9.56E-02 4.89E-05 1.09E-01 1.59E-04 1.17E-01 6.69E-04 2.7E-03 1.7E+00 366 5.9E-01 1.0E-03 991 3
Lower Bound 1.19E-02 2.55E-03 2.77E-03 3.49E-03 9.55E-02 1.09E-01 1.15E-01
Upper Bound 5.73E-02 6.58E-01 1.28E-04 1.17E-02 5.05E-02 5.78E-02 2.23E+00
nNOS DYNLL1 Best Fit 4.59E-02 7.42E-03 5.26E-01 3.98E-02 1.34E-04 3.41E-05 8.59E-03 1.01E-01 5.05E-02 3.82E-05 5.77E-02 1.42E-04 2.19E-01 1.70E-01 8.7E-05 1.6E-02 11473 6.4E+01 8.6E-05 11652 7000
Lower Bound 3.67E-02 4.21E-01 1.29E-05 6.88E-03 5.05E-02 5.75E-02 7.67E-02
Upper Bound 7.53E-02 9.25E-01 1.22E-03 1.77E-02 9.10E-02 1.03E-01 2.17E+00
nNOS DYNLL2 Best Fit 4.82E-02 5.13E-03 5.92E-01 2.95E-02 1.88E-04 4.15E-05 1.62E-02 5.39E-02 9.10E-02 3.95E-05 1.03E-01 2.06E-04 4.98E-01 2.39E-01 8.1E-05 1.2E-02 12279 8.6E+01 8.1E-05 12422 5410
Lower Bound 3.86E-02 4.73E-01 3.94E-05 1.50E-02 9.10E-02 1.03E-01 1.63E-01
Upper Bound 7.74E-03 2.08E-01 1.05E-03 2.30E-02 1.01E-01 1.11E-01 2.31E+00
myosin Va DYNLL2 Best Fit 6.19E-03 2.23E-03 1.66E-01 6.35E-03 1.59E-04 4.23E-05 1.99E-02 5.20E-02 1.01E-01 1.10E-04 1.11E-01 2.45E-04 6.98E-01 3.61E-01 3.7E-05 8.0E-03 26892 1.3E+02 3.7E-05 27107 8850
Lower Bound 5.78E-03 1.55E-01 5.04E-05 1.72E-02 1.00E-01 1.11E-01 2.07E-01
Upper Bound 4.60E-03 5.32E-03 1.42E-02 9.08E-03 9.42E-02 1.05E-01 1.92E-01
dimeric myosin Va DYNLL2 Best Fit 4.05E-03 1.68E-03 1.99E-03 2.28E-03 7.89E-03 7.05E-03 3.72E-03 2.25E-02 9.41E-02 9.53E-05 1.04E-01 3.00E-04 1.10E-01 1.26E-03 2.0E-03 2.1E+00 492 4.7E-01 6.5E-04 1536 37
Lower Bound 3.82E-03 8.18E-04 3.47E-04 7.80E-04 9.41E-02 1.04E-01 1.08E-01
Upper Bound 1.85E-02 8.44E-01 8.44E-04 3.62E-02 1.03E-01 1.21E-01 4.76E+02
Pak1 DYNLL2 Best Fit 1.47E-02 2.53E-03 6.73E-01 3.71E-02 2.97E-05 1.24E-04 2.90E-02 7.36E-02 1.03E-01 5.47E-05 1.20E-01 4.30E-04 4.51E+00 1.98E+01 2.2E-05 1.0E-03 45674 9.7E+02 2.2E-05 45721 42700
Lower Bound 1.18E-02 5.10E-01 3.42E-07 2.14E-02 1.03E-01 1.20E-01 2.35E-01
 
*In the CS model kCon, kCoff, kC+i and kC-i are the on- and off-rate constants of the binding step and the forward- and reverse-rate constants of the 
isomerization step, respectively. The f1, f2, f3 parameters are the fluorescence intensities assigned to the binding incompetent form of DYNLL, 
the binding competent form of DYNLL and the DYNLL-ligand complex, respectively. In the IF model kIon, kIoff, kI+i and kI-i are the on- and off-
rate constants of the binding step and the forward- and reverse-rate constants of the isomerization step, respectively. The f1, f2, f3 parameters are 
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the fluorescence intensities assigned to apo-DYNLL, the intermediate DYNLL-ligand complex and the final DYNLL-ligand complex, 
respectively. Errors are the standard error of fitting. The upper and lower limits of each parameter calculated by FitSpace Explorer can be found 
above and below the values, respectively. In the global analysis, most parameters were well constrained except the forward rate constant of the 
isomerisation step (kI+i) and the fluorescence level of the final complex (f3) in the IF model; and the reverse rate constant (kC-i) of the 
isomerisation step and the fluorescence level of the binding incompetent state of DYNLL (f1) in the CS model. We calculated the association and 
dissociation equilibrium constants of the binding (KCB, KdCB) and isomerisation (KCi, KdCi) steps and the association and dissociation constants of 
the entire, coupled reaction (KeqC, Kd,eqC). We also calculated the corresponding values based on the IF model (KIB, KdIB, KIi, KdIi, KeqI, Kd,eqI). 
We show Kd,eq values measured by ITC in the last column. 
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Supplemental Figure 1. Tryptophan fluorescence-based transient kinetic measurements. 
Fluorescence change of Trp54 in DYNLL isoforms was monitored following rapid mixing of DYNLL 
(3 µM monomer concentration) with different peptides at a series of peptide concentrations (post-
mixing concentrations indicated). Trp54 was selectively excited at 297 nm and the emission was 
monitored at 340 nm. Biphasic binding transients were observed. Curves represent global best-fits 
based on the conformational selection model, fitted by Kintek Explorer Pro software. 
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Supplemental Figure 2. PAK1 phosphorylates His-tagged DYNLL proteins only. Cells 
were transfected with PAK1 T423E plasmid. Cell lysates were then subjected to 
immunoprecipitation with anti-PAK1 antibody. PAK1-dependent phosphorylation of wild-
type and His-tagged DYNLL proteins was assayed in the immunoprecipitates by adding 
recombinant proteins and H4 histone in the presence of [γ-32P]ATP. Proteins in the reaction 
mixture were separated by SDS-PAGE on 15% polyacrylamide gels, and subjected to 
Coomassie staining (A) or autoradiography (B). 
 
Supplemental Experimental Procedures – Phosphorylation of DYNLL proteins by 
constitutively active PAK1 
Constitutively active PAK1 was produced by changing threonine 423 to glutamic acid, as 
described earlier (Illes et al, Cell Signal, 2005, 18:830-840). 106 COS7 cells were plated on 
10-cm dishes and transfected with Pak-T423E construct in the presence of Lipofectamine 
according to the manufacturer’s instructions. 48 hours later Pak1 was immunopericpiated with 
anti-PAK1 polyclonal antibody (Santa Cruz Biotechnology, Inc.) immobilized on protein A-
Sepharose. The beads were washed three times in the lysing buffer and three times in ‘‘kinase 
buffer’’ (25 mM HEPES pH 7.4, 10 mM MgCl2 and 0.5 mM EGTA) at 4 ºC. The reaction 
was performed in a mixture (30 µl final volume) containing the kinase buffer, the 
immunoprecipitated PAK1, 5 µg of recombinant DYNLL proteins and H4 histone, and 100 
µM ATP including 2µCi [γ-32P]ATP. The reaction was initiated by the addition of ATP. After 
incubation at 25 °C for 30 min, reaction was stopped by adding 10 µl of 4x concentrated SDS 
sample buffer. Samples were subjected to SDS-PAGE using 15% running gels. After drying, 
gels were subjected to autoradiography for 2–12 h.) 
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Supplemental Figure 3. 3D FitSpace contours of the fitted parameters in case of DYNLL2-nNOS interaction. 
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